Are selective contracts with German insurances a smarter reimbursement pathway, Tim Hering?
Within the opportunity of contracting in the German health care market, prices, reimbursement and integrated care paths could be agreed [...]
AMNOG was the end of paradise for pharmaceutical companies, correct Prof. Hammerschmidt?
What have been the main changes after 10 years of AMNOG for pharmaceutical companies? What have been the biggest successes [...]
How do innovations reach patients in German hospitals, Dr. Sebastian Casu?
How important are the famous NUBs, OPS and DRG values? How can innovations reach patients beyond administrative barriers? What are [...]